Reimbursement of pharmaceuticals: reference pricing versus health technology assessment
Michael Drummond (),
Frans Rutten and
Tom Stargardt ()
The European Journal of Health Economics, 2011, vol. 12, issue 3, 263-271
Keywords: Pharmaceuticals; Reimbursement; Cost-effectiveness analysis; Health policy; I10; I18 (search for similar items in EconPapers)
References: View references in EconPapers View complete reference list from CitEc
Citations: View citations in EconPapers (12) Track citations by RSS feed
Downloads: (external link)
Access to full text is restricted to subscribers.
This item may be available elsewhere in EconPapers: Search for items with the same title.
Export reference: BibTeX
RIS (EndNote, ProCite, RefMan)
Persistent link: https://EconPapers.repec.org/RePEc:spr:eujhec:v:12:y:2011:i:3:p:263-271
Ordering information: This journal article can be ordered from
http://www.springer. ... cs/journal/10198/PS2
Access Statistics for this article
The European Journal of Health Economics is currently edited by J.-M.G.v.d. Schulenburg
More articles in The European Journal of Health Economics from Springer, Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ) Contact information at EDIRC.
Bibliographic data for series maintained by Sonal Shukla ().